Table 3.
Serum tests and exhaled breath condensates of the exposed and control participants in the cold and warm seasons
| Variable | Cold season | Warm season | ||||
|---|---|---|---|---|---|---|
| Exposed (n = 39) |
Control (n = 28) |
p | Exposed (n = 39) |
Control (n = 28) |
p | |
| Serum test | ||||||
| IL-1β, pg/mL | 0.6 [0.2, 2.0] | 0.4 [0.0, 4.1] | 0.890 | 7.5 [7.0, 8.2] | 1.0 [0.0, 7.5] | <0.001 |
| IL-6, pg/mL | 4.8 [2.7, 9.7] | 0.9 [0.1, 2.6] | <0.001 | 10.5 [8.0, 14.2] | 8.8 [2.6, 15.5] | 0.101 |
| IL-8, pg/mL | 5.3 [3.5, 10.0] | 2.1 [0.0, 12.7] | 0.170 | 20.5 [18.0, 22.5] | 15.2 [10.9, 19.3] | 0.009 |
| IL17-A, pg/mL | 2.9 [2.3, 3.7] | 0.3 [0.0, 0.6] | <0.001 | 10.0 [9.0, 11.7] | 2.0 [0.4, 7.5] | <0.001 |
| TNF-α, pg/mL | 2.9 [2.3, 3.7] | 0.7 [0.1, 1.4] | <0.001 | 9.7 [8.0, 12.3] | 2.5 [0.9, 10.0] | 0.001 |
| hsCRP, ng/mL | 2066 [822, 4516] | 1264 [184, 2238] | 0.032 | 1187 [588, 2087] | 911 [273, 2212] | 0.403 |
| PAI-1, ng/mL | 10.5 [9.2, 11.3] | 15.2 [8.6, 29.1] | 0.078 | 21.2 [18.3, 22.6] | 18.8 [15.5, 23.7] | 0.223 |
| 8-OhdG, ng/mL | 12.3 [8.9, 19.9] | 14.5 [10.2, 26.3] | 0.233 | 8.9 [7.2, 14.5] | 13.1 [8.8, 24.1] | 0.035 |
| Exhaled breath condensate | ||||||
| IL-1β, pg/mL | 1.9 [1.1, 2.4] | 2.5 [0.8, 3.0] | 0.469 | 2.3 [1.9, 3.4] | 1.9 [1.1, 4.2] | 0.369 |
| IL-6, pg/mL | 6.3 [5.9, 7.3] | 0.0 [0.0, 0.7] | <0.001 | 7.6 [7.4, 9.6] | 9.4 [8.6, 10.8] | 0.121 |
| IL-8, pg/mL | 0.0 [0.0, 0.0] | 11.9 [0.3, 23.1] | <0.001 | 5.3 [4.7, 7.3] | 8.3 [7.3, 11.3] | 0.002 |
| IL-17A, pg/mL | 0.7 [0.3, 2.4] | 0.8 [0.0, 1.1] | 0.110 | 3.0 [2.8, 3.4] | 2.8 [2.5, 3.6] | 0.223 |
| MCP-1, pg/mL | 3.0 [1.3, 5.2] | 1.5 [0.8, 1.8] | <0.001 | 4.5 [4.0, 4.8] | 4.5 [4.3, 5.3] | 0.457 |
Data were presented as median (25th and 75th percentiles)
Abbreviations: IL, interleukin; TNF-α, tumor necrosis factor-alpha; hs-CRP, high-sensitivity C-reactive protein; PAI-1, plasminogen activator inhibitor-1; 8-OHdG, 8-hydroxy-2-deoxyguanosine; MCP-1, monocyte chemoattractant protein-1